Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All Insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies / Buy and sell DNAnexus stock
DNAnexus

DNAnexus stock

$616.31MM
Series I Valuation, Mar 2022
Buy And Sell DNAnexus StockLearn More About DNAnexus IPO
Register to buy and sell private company shares
For more details on private stock price information, financing and valuation for DNAnexus, register or log in.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

DNAnexus stock price

Forge Price 1
Price not yet available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx
Access Stock Price

DNAnexus funding rounds and valuation

Funding history chart
Funding round details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
03/08/2022 Series I $200MM $xx.xx $616.31MM Blackstone Growth, Foresite Capital, Gv, Innovatus Capital Partners, Northpond Ventures, Perceptive Advisors
Price per Share
$xx.xx
Shares Outstanding
327,976,382
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blackstone Growth, Foresite Capital, Gv, Innovatus Capital Partners, Northpond Ventures, Perceptive Advisors
06/09/2020 Series H $47.15MM $xx.xx $226.42MM First Round Capital, Foresite Capital, Gv, Northpond Ventures, Perceptive Advisors, Regeneron Pharmaceuticals, Tpg Capital
Price per Share
$xx.xx
Shares Outstanding
127,432,428
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, Foresite Capital, Gv, Northpond Ventures, Perceptive Advisors, Regeneron Pharmaceuticals, Tpg Capital
06/09/2020 Series G $15.51MM $xx.xx $226.42MM First Round Capital, Foresite Capital, Gv, Northpond Ventures, Perceptive Advisors, Regeneron Pharmaceuticals, Tpg Capital
Price per Share
$xx.xx
Shares Outstanding
42,529,695
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital, Foresite Capital, Gv, Northpond Ventures, Perceptive Advisors, Regeneron Pharmaceuticals, Tpg Capital
02/06/2019 Series F-1 $30.78MM $xx.xx $135.9MM Claremont Creek Ventures, Foresite Capital, Gv, Innovatus Capital Partners, Tpg Biotech, Wuxi Nextcode
Price per Share
$xx.xx
Shares Outstanding
91,623,776
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Claremont Creek Ventures, Foresite Capital, Gv, Innovatus Capital Partners, Tpg Biotech, Wuxi Nextcode
02/06/2019 Series F-2 $14.43MM $xx.xx $135.9MM Claremont Creek Ventures, Foresite Capital, Gv, Innovatus Capital Partners, Tpg Biotech, Wuxi Nextcode
Price per Share
$xx.xx
Shares Outstanding
40,909,900
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Claremont Creek Ventures, Foresite Capital, Gv, Innovatus Capital Partners, Tpg Biotech, Wuxi Nextcode
01/02/2018 Series E $22.74MM $xx.xx $75.08MM Claremont Creek Ventures, Existing Investors, Foresite Capital, Gv, Microsoft, Midcap Financial, Tpg Biotech, Wuxi Nextcode
Price per Share
$xx.xx
Shares Outstanding
67,694,865
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Claremont Creek Ventures, Existing Investors, Foresite Capital, Gv, Microsoft, Midcap Financial, Tpg Biotech, Wuxi Nextcode
04/22/2015 Series D $15MM $xx.xx $83.94MM Wuxi Pharmatech
Price per Share
$xx.xx
Shares Outstanding
24,402,544
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.3x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Wuxi Pharmatech
01/03/2014 Series C $18.3MM $xx.xx $35.4MM Claremont Creek Ventures, First Round Capita, Gv, Tpg Biotech
Price per Share
$xx.xx
Shares Outstanding
55,454,543
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Claremont Creek Ventures, First Round Capita, Gv, Tpg Biotech
10/12/2011 Series B $15.3MM $xx.xx $32.78MM Felicis Ventures, First Round Capital, Gv, K9 Ventures, Softtech Vc, Tpg Biotech
Price per Share
$xx.xx
Shares Outstanding
7,559,292
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
4.1x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Felicis Ventures, First Round Capital, Gv, K9 Ventures, Softtech Vc, Tpg Biotech
08/03/2009 Series A $1.55MM $xx.xx $4.43MM First Round Capital
Price per Share
$xx.xx
Shares Outstanding
1,347,823
Liquidation Pref Order
7
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.8x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
First Round Capital
Access Stock Price
Company details
DNAnexus, founded in 2009, is a cloud-based platform for biomedical informatics and data management. DNAnexus strives to provide security, scalability, and collaboration for enterprises and organizations that are pursuing genomic-based approaches to health with the goal of accelerating medical discovery. The company is headquartered in Mountain View, California.
dnanexus.com
Sector
Healthcare
Subsector
Healthcare Software
Founded
2009
Headquarters
Mountain View, CA, United States
Post-Money Valuation 3
$616.31MM
Total Funding
$1.14B
LFR Price per Share
$xx.xx
Last Funding Share Class
Series I

DNAnexus stock FAQs

To buy and sell DNAnexus stock
Can you buy DNAnexus stock?
As DNAnexus is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like DNAnexus, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.
How to buy DNAnexus stock?

To invest in a private company like DNAnexus through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
Can you sell DNAnexus stock?
Yes, you may sell the DNAnexus stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
How to sell DNAnexus stock?

If you hold private company shares of DNAnexus – whether as an employee or an early investor – Forge can help you sell them.

  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your DNAnexus on our platform.
  3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.
To learn more about DNAnexus stock
Is DNAnexus a public company?
No, DNAnexus is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
What is DNAnexus’ stock price?
DNAnexus is a privately held company and therefore does not have a public stock price. However, you may access DNAnexus private market stock price with Forge Data.
What is DNAnexus’ stock ticker symbol?
DNAnexus does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Other companies like DNAnexus in the Healthcare Software sector
Sector: Healthcare
Subsector: Healthcare Software
Last Funding Round
Company Forge Price Forge Price Change 5 Last Closed Trade Share Class Post-Money Valuation Price per Share Amount Raised
AbridgeAbridge----$xx.xxSeries E$5.3B$xx.xx$300MM
BenchlingBenchling----$xx.xxSeries F$6.1B$xx.xx$95MM
DeepScribeDeepScribe----$xx.xxSeries B$134.68MM$xx.xx$24MM
Hippocratic AIHippocratic AI----$xx.xxSeries B$1.64B$xx.xx$141MM
InnovaccerInnovaccer$3.29-6.00%$xx.xxSeries F-1$3.45B$xx.xx$153.04MM
Insilico MedicineInsilico Medicine----$xx.xx--------
OpenEvidenceOpenEvidence----$xx.xxSeries B-1$3.47B$xx.xx$30MM
Parsley HealthParsley Health----$xx.xxSeries 1$20.94MM$xx.xx$15MM
PathosPathos----$xx.xxSeries D$1.6B$xx.xx$331.82MM
Viz.aiViz.ai----$xx.xxSeries D$1.28B$xx.xx$120MM
See All Companies

Forge is your trusted partner to buy and sell DNAnexus stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Register
Trending companies

Frequently asked questions

Updated on: Jan 22, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.